Anti-MOG antibodies with longitudinally extensive transverse myelitis preceded by CLIPPERS

Neurology

Volumn 84, Issue 11, 2015, Pages 1177-1179

  Symmonds, Mkael ^a   Waters, Patrick J ^a   Küker, Wilhelm ^a   Leite, M Isabel ^a   Schulz, Ursula G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PREDNISOLONE; AUTOANTIBODY; MOG PROTEIN, HUMAN; STEROID;

ADULT; ALLODYNIA; ARTICLE; ATAXIC GAIT; CASE REPORT; CEREBROSPINAL FLUID; CLIPPERS SYNDROME; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DIZZINESS; FEMALE; FLOW CYTOMETRY; HUMAN; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PHENOTYPE; PRIORITY JOURNAL; SLURRED SPEECH; VISUAL ACUITY; BLOOD; MYELITIS, TRANSVERSE; PATHOLOGY; PONS;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MYELITIS, TRANSVERSE; PONS; STEROIDS;

EID: 84925337081     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001370     Document Type: Article

References (7)

1. Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 2010;133: 2626-2634.
2. Dudesek A, Rimmele F, Tesar S, et al. CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders. Clin Exp Immunol 2014;175:385-396.
3. Simon NG, Parratt JD, Barnett MH, et al. Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry 2012;83:15-22.
4. Taieb G, Duflos C, Renard D, et al. Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol 2012; 69:847-855.
5. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with Aquaporin-4 and myelinoligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014;71:276.
6. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibodypositive NMO spectrum disorders. Neurology 2014;82: 474-481.
7. Reindl M, Di Pauli F, Rostásy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013;9:455-461.